{"count": 5, "results": [{"_id": "35370738", "pmid": 35370738, "pmcid": "PMC8964397", "title": "Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin", "journal": "Front Pharmacol", "authors": ["Bailey CJ", "Gwilt M"], "date": "2022-03-09T00:00:00Z", "doi": "10.3389/fphar.2022.784459", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "784459", "score": 50258.574, "text_hl": " Conclusion: The pleiotropic actions of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ associated with lower background cardiovascular risk may mediate some of these effects, for example reductions of @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@, systemic @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@ and @<m>DISEASE_Thrombophilia</m> @DISEASE_MESH:D019851 @@@hypercoagulability@@@. ", "citations": {"NLM": "Bailey CJ, Gwilt M. Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin Front Pharmacol. 2022;13():784459. PMID: 35370738", "BibTeX": "@article{35370738, title={Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin}, author={Bailey CJ and Gwilt M}, journal={Front Pharmacol}, volume={13}, pages={784459}}"}}, {"_id": "37503167", "pmid": 37503167, "pmcid": "PMC10371086", "title": "High Dose of Metformin Decreases Susceptibility to Occlusive Arterial Thrombosis in Diabetic Mice", "journal": "Res Sq", "authors": ["Alvidrez RIM", "Annarapu GK", "Sriniv AJ", "Liu Z", "Yazdani HO", "Simmons RL", "Shiva S", "Neal MD", "Nolfi-Donegan D"], "date": "2023-07-11T00:00:00Z", "doi": "10.21203/rs.3.rs-3143156/v1", "meta_date_publication": "2023 Jul 11", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50247.16, "text_hl": "High doses of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ have also been associated with @<m>DISEASE_Thrombophilia</m> @DISEASE_MESH:D019851 @@@hypercoagulation@@@. ", "citations": {"NLM": "Alvidrez RIM, Annarapu GK, Sriniv AJ, Liu Z, Yazdani HO, Simmons RL, Shiva S, Neal MD, Nolfi-Donegan D. High Dose of Metformin Decreases Susceptibility to Occlusive Arterial Thrombosis in Diabetic Mice Res Sq. 2023 Jul 11;():. PMID: 37503167", "BibTeX": "@article{37503167, title={High Dose of Metformin Decreases Susceptibility to Occlusive Arterial Thrombosis in Diabetic Mice}, author={Alvidrez RIM and Annarapu GK and Sriniv AJ and Liu Z and Yazdani HO and Simmons RL and Shiva S and Neal MD and Nolfi-Donegan D}, journal={Res Sq}}"}}, {"_id": "37975061", "pmid": 37975061, "pmcid": "PMC10653203", "title": "High Dose of Metformin Decreases Susceptibility to Occlusive Arterial Thrombosis in Diabetic Mice", "journal": "J Pharm Pharmacol Res", "authors": ["Alvidrez RIM", "Annarapu GK", "Srinivasan AJ", "Liu Z", "Yazdani HO", "Nolfi-Donegan D", "Simmons RL", "Shiva S", "Neal MD"], "date": "2023-01-01T00:00:00Z", "meta_date_publication": "2023", "meta_volume": "7", "meta_issue": "4", "meta_pages": "192-202", "score": 50246.605, "text_hl": "High doses of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ have also been associated with @<m>DISEASE_Thrombophilia</m> @DISEASE_MESH:D019851 @@@hypercoagulation@@@. ", "citations": {"NLM": "Alvidrez RIM, Annarapu GK, Srinivasan AJ, Liu Z, Yazdani HO, Nolfi-Donegan D, Simmons RL, Shiva S, Neal MD. High Dose of Metformin Decreases Susceptibility to Occlusive Arterial Thrombosis in Diabetic Mice J Pharm Pharmacol Res. 2023;7(4):192-202. PMID: 37975061", "BibTeX": "@article{37975061, title={High Dose of Metformin Decreases Susceptibility to Occlusive Arterial Thrombosis in Diabetic Mice}, author={Alvidrez RIM and Annarapu GK and Srinivasan AJ and Liu Z and Yazdani HO and Nolfi-Donegan D and Simmons RL and Shiva S and Neal MD}, journal={J Pharm Pharmacol Res}, volume={7}, number={4}, pages={192-202}}"}}, {"_id": "35041121", "pmid": 35041121, "pmcid": "PMC8764325", "title": "Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes", "journal": "J Thromb Thrombolysis", "authors": ["Usman A", "Bliden KP", "Cho A", "Walia N", "Jerjian C", "Singh A", "Kundan P", "Duhan S", "Tantry US", "Gurbel PA"], "date": "2022-02-01T00:00:00Z", "doi": "10.1007/s11239-022-02631-7", "meta_date_publication": "2022 Feb", "meta_volume": "53", "meta_issue": "2", "meta_pages": "363-371", "score": 50244.45, "text_hl": "Our aim was to explore the effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on markers of @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@, oxidative stress, and @<m>DISEASE_Thrombophilia</m> @DISEASE_MESH:D019851 @@@hypercoagulability@@@, and on clinical outcomes. ", "citations": {"NLM": "Usman A, Bliden KP, Cho A, Walia N, Jerjian C, Singh A, Kundan P, Duhan S, Tantry US, Gurbel PA. Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes J Thromb Thrombolysis. 2022 Feb;53(2):363-371. PMID: 35041121", "BibTeX": "@article{35041121, title={Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes}, author={Usman A and Bliden KP and Cho A and Walia N and Jerjian C and Singh A and Kundan P and Duhan S and Tantry US and Gurbel PA}, journal={J Thromb Thrombolysis}, volume={53}, number={2}, pages={363-371}}"}}, {"_id": "15497018", "pmid": 15497018, "title": "Pregnancy loss, polycystic ovary syndrome, thrombophilia, hypofibrinolysis, enoxaparin, metformin.", "journal": "Clin Appl Thromb Hemost", "authors": ["Glueck CJ", "Wang P", "Goldenberg N", "Sieve L"], "date": "2004-10-01T00:00:00Z", "doi": "10.1177/107602960401000404", "meta_date_publication": "2004 Oct", "meta_volume": "10", "meta_issue": "4", "meta_pages": "323-34", "score": 50062.95, "text_hl": "@DISEASE_Abortion_Spontaneous @DISEASE_MESH:D000022 @@@Pregnancy loss@@@, @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@, @<m>DISEASE_Thrombophilia</m> @DISEASE_MESH:D019851 @@@thrombophilia@@@, hypofibrinolysis, @CHEMICAL_Enoxaparin @CHEMICAL_MESH:D017984 @@@enoxaparin@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@.", "citations": {"NLM": "Glueck CJ, Wang P, Goldenberg N, Sieve L. Pregnancy loss, polycystic ovary syndrome, thrombophilia, hypofibrinolysis, enoxaparin, metformin. Clin Appl Thromb Hemost. 2004 Oct;10(4):323-34. PMID: 15497018", "BibTeX": "@article{15497018, title={Pregnancy loss, polycystic ovary syndrome, thrombophilia, hypofibrinolysis, enoxaparin, metformin.}, author={Glueck CJ and Wang P and Goldenberg N and Sieve L}, journal={Clin Appl Thromb Hemost}, volume={10}, number={4}, pages={323-34}}"}}]}